Year |
Citation |
Score |
2023 |
Hoppe ER, Udy DB, Bradley RK. Recursive splicing discovery using lariats in total RNA sequencing. Life Science Alliance. 6. PMID 37137707 DOI: 10.26508/lsa.202201889 |
0.304 |
|
2023 |
Bradley RK, Anczuków O. RNA splicing dysregulation and the hallmarks of cancer. Nature Reviews. Cancer. PMID 36627445 DOI: 10.1038/s41568-022-00541-7 |
0.364 |
|
2022 |
Wang E, Pineda JMB, Kim WJ, Chen S, Bourcier J, Stahl M, Hogg SJ, Bewersdorf JP, Han C, Singer ME, Cui D, Erickson CE, Tittley SM, Penson AV, Knorr K, ... ... Bradley RK, et al. Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia. Cancer Cell. PMID 36563682 DOI: 10.1016/j.ccell.2022.12.002 |
0.515 |
|
2022 |
North K, Benbarche S, Liu B, Pangallo J, Chen S, Stahl M, Bewersdorf JP, Stanley RF, Erickson C, Cho H, Pineda JMB, Thomas JD, Polaski JT, Belleville AE, Gabel AM, ... ... Bradley RK, et al. Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells. Nature Biotechnology. PMID 35241838 DOI: 10.1038/s41587-022-01224-2 |
0.811 |
|
2021 |
Clough CA, Pangallo J, Sarchi M, Ilagan JO, North K, Bergantinos R, Stolla MC, Naru J, Nugent P, Kim E, Stirewalt DL, Subramaniam AR, Abdel-Wahab O, Abkowitz JL, Bradley RK, et al. Coordinated mis-splicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome. Blood. PMID 34861039 DOI: 10.1182/blood.2021012652 |
0.758 |
|
2021 |
Beauchamp EM, Leventhal M, Bernard E, Hoppe ER, Todisco G, Creignou M, Gallì A, Castellano CA, McConkey M, Tarun A, Wong W, Schenone M, Stanclift C, Tanenbaum B, Malolepsza E, ... ... Bradley RK, et al. is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicing. Blood Cancer Discovery. 2: 500-517. PMID 34568833 DOI: 10.1158/2643-3230.BCD-20-0224 |
0.37 |
|
2021 |
Lu SX, De Neef E, Thomas JD, Sabio E, Rousseau B, Gigoux M, Knorr DA, Greenbaum B, Elhanati Y, Hogg SJ, Chow A, Ghosh A, Xie A, Zamarin D, Cui D, ... ... Bradley RK, et al. Pharmacologic modulation of RNA splicing enhances anti-tumor immunity. Cell. PMID 34171309 DOI: 10.1016/j.cell.2021.05.038 |
0.518 |
|
2021 |
Inoue D, Polaski JT, Taylor J, Castel P, Chen S, Kobayashi S, Hogg SJ, Hayashi Y, Pineda JMB, El Marabti E, Erickson C, Knorr K, Fukumoto M, Yamazaki H, Tanaka A, ... ... Bradley RK, et al. Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition. Nature Genetics. PMID 33846634 DOI: 10.1038/s41588-021-00828-9 |
0.727 |
|
2021 |
Chew GL, Bleakley M, Bradley RK, Malik HS, Henikoff S, Molaro A, Sarthy J. Short H2A histone variants are expressed in cancer. Nature Communications. 12: 490. PMID 33473122 DOI: 10.1038/s41467-020-20707-x |
0.568 |
|
2021 |
Polaski JT, Udy DB, Escobar-Hoyos LF, Askan G, D Leach SD, Ventura A, Kannan R, Bradley RK. The origins and consequences of variants in pancreatic adenosquamous carcinoma. Elife. 10. PMID 33404013 DOI: 10.7554/eLife.62209 |
0.334 |
|
2020 |
Taylor J, Mi X, North KD, Binder M, Penson A, Lasho TL, Knorr K, Haddadin M, Liu B, Pangallo J, Benbarche S, Wiseman DH, Tefferi A, Halene S, Liang Y, ... ... Bradley RK, et al. Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms. Blood. PMID 32640014 DOI: 10.1182/Blood.2020006868 |
0.802 |
|
2020 |
Escobar-Hoyos LF, Penson A, Kannan R, Cho H, Pan CH, Singh RK, Apken LH, Hobbs GA, Luo R, Lecomte N, Babu S, Pan FC, Alonso-Curbelo D, Morris JP, Askan G, ... ... Bradley RK, et al. Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer. Cancer Cell. PMID 32559497 DOI: 10.1016/J.Ccell.2020.05.010 |
0.443 |
|
2020 |
Jones TI, Chew GL, Barraza-Flores P, Schreier S, Ramirez M, Wuebbles RD, Burkin DJ, Bradley RK, Jones PL. Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity. Skeletal Muscle. 10: 8. PMID 32278354 DOI: 10.1186/S13395-020-00227-4 |
0.565 |
|
2020 |
Rahman MA, Lin KT, Bradley RK, Abdel-Wahab O, Krainer AR. Recurrent SRSF2 mutations in MDS affect both splicing and NMD. Genes & Development. PMID 32001512 DOI: 10.1101/Gad.332270.119 |
0.501 |
|
2020 |
Pangallo J, Kiladjian JJ, Cassinat B, Renneville A, Taylor J, Polaski JT, North KD, Abdel-Wahab O, Bradley RK. Rare and private spliceosomal gene mutations drive partial, complete, and dual phenocopies of hotspot alterations. Blood. PMID 31961934 DOI: 10.1182/Blood.2019002894 |
0.797 |
|
2020 |
Thomas JD, Polaski JT, Feng Q, De Neef EJ, Hoppe ER, McSharry MV, Pangallo J, Gabel AM, Belleville AE, Watson J, Nkinsi NT, Berger AH, Bradley RK. RNA isoform screens uncover the essentiality and tumor-suppressor activity of ultraconserved poison exons. Nature Genetics. PMID 31911676 DOI: 10.1038/S41588-019-0555-Z |
0.796 |
|
2019 |
Inoue D, Chew GL, Liu B, Michel BC, Pangallo J, D'Avino AR, Hitchman T, North K, Lee SC, Bitner L, Block A, Moore AR, Yoshimi A, Escobar-Hoyos L, Cho H, ... ... Bradley RK, et al. Spliceosomal disruption of the non-canonical BAF complex in cancer. Nature. PMID 31597964 DOI: 10.1038/S41586-019-1646-9 |
0.813 |
|
2019 |
Yoshimi A, Lin KT, Wiseman DH, Rahman MA, Pastore A, Wang B, Lee SC, Micol JB, Zhang XJ, de Botton S, Penard-Lacronique V, Stein EM, Cho H, Miles RE, Inoue D, ... ... Bradley RK, et al. Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis. Nature. PMID 31578525 DOI: 10.1038/S41586-019-1618-0 |
0.785 |
|
2019 |
Dvinge H, Guenthoer J, Porter PL, Bradley RK. RNA components of the spliceosome regulate tissue- and cancer-specific alternative splicing. Genome Research. PMID 31434678 DOI: 10.1101/Gr.246678.118 |
0.768 |
|
2019 |
Chew GL, Campbell AE, De Neef E, Sutliff NA, Shadle SC, Tapscott SJ, Bradley RK. DUX4 Suppresses MHC Class I to Promote Cancer Immune Evasion and Resistance to Checkpoint Blockade. Developmental Cell. PMID 31327741 DOI: 10.1016/J.Devcel.2019.06.011 |
0.699 |
|
2019 |
Palangat M, Anastasakis DG, Fei DL, Lindblad KE, Bradley R, Hourigan CS, Hafner M, Larson DR. The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation. Genes & Development. PMID 30842218 DOI: 10.1101/Gad.319590.118 |
0.473 |
|
2019 |
Jagannathan S, Ogata Y, Gafken PR, Tapscott SJ, Bradley RK. Quantitative proteomics reveals key roles for post-transcriptional gene regulation in the molecular pathology of FSHD. Elife. 8. PMID 30644821 DOI: 10.7554/Elife.41740 |
0.701 |
|
2019 |
Pufall MA, Fang M, Bradley RK, Guo-Liang C, Lanier R, Tasian SK. Glucocorticoids Regulate the Splicing Factor MBNL1, a Potential Control Point for B-Cell Specification Blood. 134: 2478-2478. DOI: 10.1182/Blood-2019-131322 |
0.346 |
|
2019 |
Clough C, Busch S, Pangallo J, Bradley RK, Doulatov S. Probing Aberrant Splicing in a Novel Model of SF3B1-Mutant Myelodysplastic Syndromes Blood. 134: 1706-1706. DOI: 10.1182/Blood-2019-129176 |
0.423 |
|
2019 |
Inoue D, Guo-Liang C, Liu B, Lee SC, Michel BC, Pangallo J, D'Avino AR, North K, Bitner LE, Xiao M, Kobayashi S, Yoshimi A, Cho H, Lu SX, Taylor J, ... ... Bradley RK, et al. Spliceosomal Disruption of the Non-Canonical SWI/SNF Chromatin Remodeling Complex in SF3B1 Mutant Leukemias Blood. 134: 637-637. DOI: 10.1182/Blood-2019-124616 |
0.493 |
|
2018 |
Fei DL, Zhen T, Durham B, Ferrarone J, Zhang T, Garrett L, Yoshimi A, Abdel-Wahab O, Bradley RK, Liu P, Varmus H. Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene . Proceedings of the National Academy of Sciences of the United States of America. PMID 30322915 DOI: 10.1073/Pnas.1812669115 |
0.41 |
|
2018 |
Lee SC, North K, Kim E, Jang E, Obeng E, Lu SX, Liu B, Inoue D, Yoshimi A, Ki M, Yeo M, Zhang XJ, Kim MK, Cho H, Chung YR, ... ... Bradley RK, et al. Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations. Cancer Cell. 34: 225-241.e8. PMID 30107174 DOI: 10.1016/J.Ccell.2018.07.003 |
0.496 |
|
2018 |
Chang CJ, Kotini AG, Olszewska M, Georgomanoli M, Teruya-Feldstein J, Sperber H, Sanchez R, DeVita R, Martins TJ, Abdel-Wahab O, Bradley RK, Papapetrou EP. Dissecting the Contributions of Cooperating Gene Mutations to Cancer Phenotypes and Drug Responses with Patient-Derived iPSCs. Stem Cell Reports. PMID 29681544 DOI: 10.1016/J.Stemcr.2018.03.020 |
0.4 |
|
2018 |
Pineda JMB, Bradley RK. Most human introns are recognized via multiple and tissue-specific branchpoints. Genes & Development. PMID 29666160 DOI: 10.1101/Gad.312058.118 |
0.431 |
|
2018 |
Lee SC, North K, Chen C, Kim E, Lu SX, Ki M, Garippa R, Lowe SW, Bradley RK, Abdel-Wahab OI. Dependency of Spliceosomal Mutant MDS on Innate Immune Signaling Blood. 132: 937-937. DOI: 10.1182/Blood-2018-99-111552 |
0.423 |
|
2017 |
Jagannathan S, Bradley RK. Congenital myotonic dystrophy-an RNA-mediated disease across a developmental continuum. Genes & Development. 31: 1067-1068. PMID 28717044 DOI: 10.1101/Gad.302893.117 |
0.587 |
|
2017 |
Feng Q, Jagannathan S, Bradley RK. The RNA Surveillance Factor UPF1 Represses Myogenesis via Its E3 Ubiquitin Ligase Activity. Molecular Cell. PMID 28669802 DOI: 10.1016/J.Molcel.2017.05.034 |
0.724 |
|
2016 |
Jagannathan S, Shadle SC, Resnick R, Snider L, Tawil RN, van der Maarel SM, Bradley RK, Tapscott SJ. Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells. Human Molecular Genetics. 25: 4419-4431. PMID 28171552 DOI: 10.1093/Hmg/Ddw271 |
0.659 |
|
2016 |
Fei DL, Motowski H, Chatrikhi R, Prasad S, Yu J, Gao S, Kielkopf CL, Bradley RK, Varmus H. Wild-Type U2AF1 Antagonizes the Splicing Program Characteristic of U2AF1-Mutant Tumors and Is Required for Cell Survival. Plos Genetics. 12: e1006384. PMID 27776121 DOI: 10.1371/Journal.Pgen.1006384 |
0.431 |
|
2016 |
Uo T, Dvinge H, Sprenger CC, Bradley RK, Nelson PS, Plymate SR. Systematic and functional characterization of novel androgen receptor variants arising from alternative splicing in the ligand-binding domain. Oncogene. PMID 27694897 DOI: 10.1038/Onc.2016.313 |
0.725 |
|
2016 |
Jagannathan S, Bradley RK. Translational plasticity facilitates the accumulation of nonsense genetic variants in the human population. Genome Research. PMID 27646533 DOI: 10.1101/Gr.205070.116 |
0.566 |
|
2016 |
Jagannathan S, Shadle S, Resnick R, Snider L, Tawil RN, van der Maarel SM, Bradley RK, Tapscott SJ. Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells. Human Molecular Genetics. PMID 27530253 DOI: 10.1093/hmg/ddw271 |
0.632 |
|
2016 |
Dvinge H, Kim E, Abdel-Wahab O, Bradley RK. RNA splicing factors as oncoproteins and tumour suppressors. Nature Reviews. Cancer. PMID 27282250 DOI: 10.1038/Nrc.2016.51 |
0.792 |
|
2016 |
Lee SC, Dvinge H, Kim E, Cho H, Micol JB, Chung YR, Durham BH, Yoshimi A, Kim YJ, Thomas M, Lobry C, Chen CW, Pastore A, Taylor J, Wang X, ... ... Bradley RK, et al. Erratum: Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins. Nature Medicine. 22: 692. PMID 27270779 DOI: 10.1038/nm0616-692d |
0.732 |
|
2016 |
Inoue D, Bradley RK, Abdel-Wahab O. Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesis. Genes & Development. 30: 989-1001. PMID 27151974 DOI: 10.1101/Gad.278424.116 |
0.453 |
|
2016 |
Lee SC, Dvinge H, Kim E, Cho H, Micol JB, Chung YR, Durham BH, Yoshimi A, Kim YJ, Thomas M, Lobry C, Chen CW, Pastore A, Taylor J, Wang X, ... ... Bradley RK, et al. Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins. Nature Medicine. PMID 27135740 DOI: 10.1038/Nm.4097 |
0.769 |
|
2016 |
Cameron RC, McKinstry M, De La Garza A, Nik S, Smith PG, Buonamici S, Bradley RK, Bowman TV. A Chemical Modifier Screen in Zebrafish Mutants for the Spliceosomal Component Sf3b1reveals Genotype-Selective Vulnerabilities Blood. 128: 965-965. DOI: 10.1182/Blood.V128.22.965.965 |
0.43 |
|
2016 |
Chang C, Kotini A, Teruya-Feldstein J, Abdel-Wahab O, Bradley R, Papapetrou EP. Isogenic iPSC Models of SRSF2-Mutant Myelodysplastic Syndrome Capture Disease Phenotypes, Splicing Defects and Drug Responses Blood. 128: 962-962. DOI: 10.1182/Blood.V128.22.962.962 |
0.494 |
|
2016 |
Lee SC, Dilai K, Obeng EA, Kim E, Micol J, Yoshimi A, Willekens C, Inoue D, Saada V, Cho H, Chung YR, Palacino J, Seiler M, Buonamici S, Smith P, ... ... Bradley R, et al. Synthetic Lethal Interactions of MDS-Associated Spliceosomal Gene Mutations Identifies the Basis for Their Mutual Exclusivity Blood. 128: 961-961. DOI: 10.1182/Blood.V128.22.961.961 |
0.468 |
|
2016 |
Fei D, Motowski H, Prasad S, Yu J, Bradley R, Varmus H. Abstract 4163: Molecular and physiological effects of splicing factor mutant U2AF1 in human lung cell lines and in mice Cancer Research. 76: 4163-4163. DOI: 10.1158/1538-7445.Am2016-4163 |
0.422 |
|
2016 |
Uo T, Dvinge H, Sprenger CC, Bradley RK, Nelson PS, Plymate SR. Abstract 1819: Intrinsic determinants of constitutive activity of exon-skipping variants of androgen receptor in castration resistant prostate cancer Cancer Research. 76: 1819-1819. DOI: 10.1158/1538-7445.Am2016-1819 |
0.725 |
|
2015 |
Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, Montgomery B, Taplin ME, Pritchard CC, Attard G, Beltran H, Abida W, Bradley RK, Vinson J, Cao X, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 162: 454. PMID 28843286 DOI: 10.1016/J.Cell.2015.06.053 |
0.708 |
|
2015 |
Hickey TE, Irvine CM, Dvinge H, Tarulli GA, Hanson AR, Ryan NK, Pickering MA, Birrell SN, Hu DG, Mackenzie PI, Russell R, Caldas C, Raj GV, Dehm SM, Plymate SR, ... Bradley RK, et al. Expression of androgen receptor splice variants in clinical breast cancers. Oncotarget. PMID 26554309 DOI: 10.18632/Oncotarget.6296 |
0.73 |
|
2015 |
Dvinge H, Bradley RK. Widespread intron retention diversifies most cancer transcriptomes. Genome Medicine. 7: 45. PMID 26113877 DOI: 10.1186/S13073-015-0168-9 |
0.782 |
|
2015 |
Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, Montgomery B, Taplin ME, Pritchard CC, Attard G, Beltran H, Abida W, Bradley RK, Vinson J, Cao X, et al. Integrative clinical genomics of advanced prostate cancer. Cell. 161: 1215-28. PMID 26000489 DOI: 10.1016/J.Cell.2015.05.001 |
0.735 |
|
2015 |
Kim E, Ilagan JO, Liang Y, Daubner GM, Lee SC, Ramakrishnan A, Li Y, Chung YR, Micol JB, Murphy ME, Cho H, Kim MK, Zebari AS, Aumann S, Park CY, ... ... Bradley RK, et al. SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition. Cancer Cell. 27: 617-30. PMID 25965569 DOI: 10.1016/J.Ccell.2015.04.006 |
0.474 |
|
2015 |
Feng Q, Snider L, Jagannathan S, Tawil R, van der Maarel SM, Tapscott SJ, Bradley RK. A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy. Elife. 4. PMID 25564732 DOI: 10.7554/Elife.04996 |
0.746 |
|
2015 |
Ilagan JO, Ramakrishnan A, Hayes B, Murphy ME, Zebari AS, Bradley P, Bradley RK. U2AF1 mutations alter splice site recognition in hematological malignancies. Genome Research. 25: 14-26. PMID 25267526 DOI: 10.1101/Gr.181016.114 |
0.487 |
|
2015 |
Lee SC, Dvinge H, Kim E, Cho H, Chung YR, Micol J, Durham B, Kim YJ, Thomas M, Lobry C, Buonamici S, Smith P, Bradley RK, Abdel-Wahab O. Therapeutic Targeting of Spliceosomal Mutant Myeloid Leukemias through Modulation of Splicing Catalysis Blood. 126: 4-4. DOI: 10.1182/Blood.V126.23.4.4 |
0.766 |
|
2015 |
Kim E, Ilagan JO, Lee S, Ramakrishnan A, Chung YR, Micol J, Murphy ME, Kim M, Zebari AS, Buonamici S, Smith P, Deeg HJ, Lobry C, Aifantis I, Bradley RK, et al. Abstract IA36:SRSF2mutations impair hematopoietic differentiation by altering exonic splicing enhancer preference. Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Hemmal14-Ia36 |
0.508 |
|
2015 |
Uo T, Dvinge H, Sprenger CC, Sun S, Bradley RK, Nelson PS, Plymate SR. Abstract 4676: In silico and in vitro analyses of androgen receptor splicing variants with a special focus on human patient samples Endocrinology. 75: 4676-4676. DOI: 10.1158/1538-7445.Am2015-4676 |
0.698 |
|
2015 |
Abeshouse A, Ahn J, Akbani R, Ally A, Amin S, Andry CD, Annala M, Aprikian A, Armenia J, Arora A, Auman JT, Balasundaram M, Balu S, Barbieri CE, Bauer T, ... ... Bradley RK, et al. The Molecular Taxonomy of Primary Prostate Cancer Cell. 163: 1011-1025. DOI: 10.1016/j.cell.2015.10.025 |
0.687 |
|
2014 |
Dvinge H, Ries RE, Ilagan JO, Stirewalt DL, Meshinchi S, Bradley RK. Sample processing obscures cancer-specific alterations in leukemic transcriptomes. Proceedings of the National Academy of Sciences of the United States of America. 111: 16802-7. PMID 25385641 DOI: 10.1182/Blood.V124.21.2201.2201 |
0.773 |
|
2014 |
Feng Q, Snider L, Jagannathan S, Tawil R, Maarel SMvd, Tapscott SJ, Bradley RK. Author response: A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy Elife. DOI: 10.7554/Elife.04996.010 |
0.658 |
|
2014 |
Kim E, Ilagan JO, Lee S, Ramakrishnan A, Chung YR, Micol J, Murphy ME, Kim M, Zebari AS, Feala J, Buonamici S, Smith PG, Deeg HJ, Lobry C, Aifantis I, ... Bradley RK, et al. SRSF2 Mutations Impair Hematopoietic Differentiation By Altering Exonic Splicing Enhancer Preference Blood. 124: 824-824. DOI: 10.1182/Blood.V124.21.824.824 |
0.502 |
|
2014 |
Ilagan JO, Ramakrishnan A, Hayes B, Murphy ME, Zebari AS, Bradley P, Bradley RK. U2AF1 Mutations Cause Allele-Specific Alterations in 3' Splice Site Recognition in Myeloid Malignancies Blood. 124: 1889-1889. DOI: 10.1182/Blood.V124.21.1889.1889 |
0.475 |
|
2013 |
Hubert CG, Bradley RK, Ding Y, Toledo CM, Herman J, Skutt-Kakaria K, Girard EJ, Davison J, Berndt J, Corrin P, Hardcastle J, Basom R, Delrow JJ, Webb T, Pollard SM, et al. Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A. Genes & Development. 27: 1032-45. PMID 23651857 DOI: 10.1101/Gad.212548.112 |
0.377 |
|
2013 |
Xi Z, Wang Y, Bradley RK, Sugumaran M, Marx CJ, Rest JS, Davis CC. Massive mitochondrial gene transfer in a parasitic flowering plant clade. Plos Genetics. 9: e1003265. PMID 23459037 DOI: 10.1371/Journal.Pgen.1003265 |
0.303 |
|
2013 |
Klattenhoff CA, Scheuermann JC, Surface LE, Bradley RK, Fields PA, Steinhauser ML, Ding H, Butty VL, Torrey L, Haas S, Abo R, Tabebordbar M, Lee RT, Burge CB, Boyer LA. Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell. 152: 570-83. PMID 23352431 DOI: 10.1016/J.Cell.2013.01.003 |
0.704 |
|
2013 |
Hubert CG, Bradley RK, Ding Y, Chad TM, Skutt-Kakaria K, Girard EJ, Davison J, Berndt J, Corrin P, Basom R, Delrow JJ, Webb T, Pollard SM, Lee J, Olson JM, et al. Abstract A20: Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Pms-A20 |
0.404 |
|
2012 |
Satija R, Bradley RK. The TAGteam motif facilitates binding of 21 sequence-specific transcription factors in the Drosophila embryo. Genome Research. 22: 656-65. PMID 22247430 DOI: 10.1101/Gr.130682.111 |
0.356 |
|
2012 |
Bradley RK, Merkin J, Lambert NJ, Burge CB. Alternative splicing of RNA triplets is often regulated and accelerates proteome evolution. Plos Biology. 10: e1001229. PMID 22235189 DOI: 10.1371/Journal.Pbio.1001229 |
0.738 |
|
2011 |
Friedland J, Sang J, Modi S, Bradley R, El-Hariry I, Wada Y, Proia D. P3-17-05: Beyond HER2 and Hormonal Agents: The Heat Shock Protein 90 Inhibitor Ganetespib as a Potential New Breast Cancer Therapy. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P3-17-05 |
0.326 |
|
2010 |
Bradley RK, Li XY, Trapnell C, Davidson S, Pachter L, Chu HC, Tonkin LA, Biggin MD, Eisen MB. Binding site turnover produces pervasive quantitative changes in transcription factor binding between closely related Drosophila species. Plos Biology. 8: e1000343. PMID 20351773 DOI: 10.1371/Journal.Pbio.1000343 |
0.561 |
|
2009 |
Bradley RK, Holmes I. Evolutionary triplet models of structured RNA. Plos Computational Biology. 5: e1000483. PMID 19714212 DOI: 10.1371/Journal.Pcbi.1000483 |
0.553 |
|
2009 |
Bradley RK, Uzilov AV, Skinner ME, Bendaña YR, Barquist L, Holmes I. Evolutionary modeling and prediction of non-coding RNAs in Drosophila. Plos One. 4: e6478. PMID 19668382 DOI: 10.1371/Journal.Pone.0006478 |
0.539 |
|
2009 |
Bradley RK, Roberts A, Smoot M, Juvekar S, Do J, Dewey C, Holmes I, Pachter L. Fast statistical alignment. Plos Computational Biology. 5: e1000392. PMID 19478997 DOI: 10.1371/Journal.Pcbi.1000392 |
0.517 |
|
2008 |
Varadarajan A, Bradley RK, Holmes IH. Tools for simulating evolution of aligned genomic regions with integrated parameter estimation. Genome Biology. 9: R147. PMID 18840304 DOI: 10.1186/Gb-2008-9-10-R147 |
0.51 |
|
2008 |
Bradley RK, Pachter L, Holmes I. Specific alignment of structured RNA: stochastic grammars and sequence annealing. Bioinformatics (Oxford, England). 24: 2677-83. PMID 18796475 DOI: 10.1093/Bioinformatics/Btn495 |
0.574 |
|
2007 |
Clark AG, Eisen MB, Smith DR, Bergman CM, Oliver B, Markow TA, Kaufman TC, Kellis M, Gelbart W, Iyer VN, Pollard DA, Sackton TB, Larracuente AM, Singh ND, ... ... Bradley RK, et al. Evolution of genes and genomes on the Drosophila phylogeny. Nature. 450: 203-18. PMID 17994087 DOI: 10.1038/Nature06341 |
0.762 |
|
2007 |
Bradley RK, Holmes I. Transducers: an emerging probabilistic framework for modeling indels on trees. Bioinformatics (Oxford, England). 23: 3258-62. PMID 17804440 DOI: 10.1093/Bioinformatics/Btm402 |
0.504 |
|
2006 |
Klosterman PS, Uzilov AV, Bendaña YR, Bradley RK, Chao S, Kosiol C, Goldman N, Holmes I. XRate: a fast prototyping, training and annotation tool for phylo-grammars. Bmc Bioinformatics. 7: 428. PMID 17018148 DOI: 10.1186/1471-2105-7-428 |
0.538 |
|
Low-probability matches (unlikely to be authored by this person) |
2013 |
Awada A, Rodriguez AA, Kong A, Erban JK, Cortes J, Mano MS, Perez EA, El Hariry I, Vukovic VM, Teofilovici F, Yalcin I, Bradley R, Cameron DA. The ENCHANT-1 trial (NCT01677455): An open label multicenter phase II proof of concept study evaluating first-line ganetespib monotherapy in women with metastatic HER2-positive or triple-negative breast cancer (TNBC). Journal of Clinical Oncology. 31: TPS1136-TPS1136. DOI: 10.1200/Jco.2013.31.15_Suppl.Tps1136 |
0.295 |
|
2016 |
Bowman T, Cameron R, McKinstry M, De La Garza A, Nik S, Payne S, Smith P, Buonamici S, Bradley R. The spliceosomal component SF3B1 is essential for hematopoietic differentiation and splicing fidelity Experimental Hematology. 44: S51. DOI: 10.1016/J.Exphem.2016.06.071 |
0.29 |
|
2018 |
Blazquez L, Emmett W, Faraway R, Pineda JMB, Bajew S, Gohr A, Haberman N, Sibley CR, Bradley RK, Irimia M, Ule J. Exon Junction Complex Shapes the Transcriptome by Repressing Recursive Splicing. Molecular Cell. 72: 496-509.e9. PMID 30388411 DOI: 10.1016/J.Molcel.2018.09.033 |
0.28 |
|
2021 |
Parrish PCR, Thomas JD, Gabel AM, Kamlapurkar S, Bradley RK, Berger AH. Discovery of synthetic lethal and tumor suppressor paralog pairs in the human genome. Cell Reports. 36: 109597. PMID 34469736 DOI: 10.1016/j.celrep.2021.109597 |
0.276 |
|
2013 |
Awada A, Spector N, El-Hariry I, Rodriguez A, Erban J, Cortes J, Gomez H, Kong A, Hickish T, Fein L, Vahdat L, MacPherson I, Canon J, Mansoor S, Giovanne A, ... ... Bradley R, et al. Abstract P2-16-23: The ENCHANT-1 trial (NCT01677455): An open label multicenter phase 2 proof of concept study evaluating first line ganetespib monotherapy in women with metastatic HER2 positive or triple negative breast cancer (TNBC) Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P2-16-23 |
0.272 |
|
2023 |
Sui P, Ge G, Chen S, Bai J, Rubalcava IP, Yang H, Guo Y, Zhang P, Li Y, Medina EA, Xu M, Abdel-Wahab O, Bradley R, Yang FC. SRSF2 mutation cooperates with ASXL1 truncated alteration to accelerate leukemogenesis. Leukemia. PMID 38017104 DOI: 10.1038/s41375-023-02094-6 |
0.271 |
|
2017 |
Uo T, Sprenger CC, Sun S, Bradley RK, Nelson PS, Plymate SR. Abstract 5643: Physical and functional interactions of exon-skipping variants of androgen receptor with the full-length counterpart Endocrinology. 77: 5643-5643. DOI: 10.1158/1538-7445.Am2017-5643 |
0.261 |
|
2010 |
Lancet JE, Smith BD, Bradley R, Komrokji RS, Teofilovici F, Rizzieri DA. A Phase I/II Trial of the Potent Hsp90 Inhibitor STA-9090 Administered Once Weekly In Patients with Advanced Hematologic Malignancies Blood. 116: 3294-3294. DOI: 10.1182/Blood.V116.21.3294.3294 |
0.252 |
|
2018 |
Jones JR, Kong L, Hanna MG, Hoffman B, Krencik R, Bradley R, Hagemann T, Choi J, Doers M, Dubovis M, Sherafat MA, Bhattacharyya A, Kendziorski C, Audhya A, Messing A, et al. Mutations in GFAP Disrupt the Distribution and Function of Organelles in Human Astrocytes. Cell Reports. 25: 947-958.e4. PMID 30355500 DOI: 10.1016/J.Celrep.2018.09.083 |
0.252 |
|
2023 |
Pineda JMB, Bradley RK. DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers. Biorxiv : the Preprint Server For Biology. PMID 37502871 DOI: 10.1101/2023.07.10.548412 |
0.248 |
|
2021 |
Vichas A, Riley AK, Nkinsi NT, Kamlapurkar S, Parrish PCR, Lo A, Duke F, Chen J, Fung I, Watson J, Rees M, Gabel AM, Thomas JD, Bradley RK, Lee JK, et al. Integrative oncogene-dependency mapping identifies RIT1 vulnerabilities and synergies in lung cancer. Nature Communications. 12: 4789. PMID 34373451 DOI: 10.1038/s41467-021-24841-y |
0.246 |
|
2022 |
Choudhary GS, Pellagatti A, Agianian B, Smith MA, Bhagat TD, Gordon-Mitchell S, Sahu S, Pandey S, Shah N, Aluri S, Aggarwal R, Aminov S, Schwartz L, Steeples V, Booher RN, ... ... Bradley RK, et al. Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations. Elife. 11. PMID 36040792 DOI: 10.7554/eLife.78136 |
0.243 |
|
2021 |
Takao S, Forbes L, Uni M, Cheng S, Pineda JMB, Tarumoto Y, Cifani P, Minuesa G, Chen C, Kharas MG, Bradley RK, Vakoc Md PhD C, Koche RP, Kentsis A. Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia. Elife. 10. PMID 33527899 DOI: 10.7554/eLife.65905 |
0.239 |
|
2010 |
Padmanabhan S, Kelly KR, Heaney M, Hodges S, Chanel S, Frattini M, Swords R, Bradley R, Teofilovici F, DeAngelo DJ. A Phase I Study of the Potent Hsp90 Inhibitor STA-9090 Administered Twice Weekly In Subjects with Hematologic Malignancies Blood. 116: 2898-2898. DOI: 10.1182/Blood.V116.21.2898.2898 |
0.233 |
|
2012 |
Xi Z, Bradley RK, Wurdack KJ, Wong K, Sugumaran M, Bomblies K, Rest JS, Davis CC. Horizontal transfer of expressed genes in a parasitic flowering plant. Bmc Genomics. 13: 227. PMID 22681756 DOI: 10.1186/1471-2164-13-227 |
0.231 |
|
2013 |
Khattak AG, Haq MU, Kaweeta F, Kocak M, Bradley R, Weir AB. Impact Of Patient, Disease and Plasma Exchange Characteristics On The Outcomes Of Thrombotic Thrombocytopenic Purpura In a Retrospective Cohort Study Blood. 122: 2359-2359. DOI: 10.1182/Blood.V122.21.2359.2359 |
0.217 |
|
2024 |
Gabel AM, Belleville AE, Thomas JD, McKellar SA, Nicholas TR, Banjo T, Crosse EI, Bradley RK. Multiplexed screening reveals how cancer-specific alternative polyadenylation shapes tumor growth in vivo. Nature Communications. 15: 959. PMID 38302465 DOI: 10.1038/s41467-024-44931-x |
0.198 |
|
2005 |
Gubser SS, Bradley RK. Degenerate eigenvalues for Hamiltonians with no obvious symmetries Advances in Theoretical and Mathematical Physics. 9: 593-602. DOI: 10.4310/Atmp.2005.V9.N4.A4 |
0.197 |
|
2022 |
Udy DB, Bradley RK. Nonsense-mediated mRNA decay uses complementary mechanisms to suppress mRNA and protein accumulation. Life Science Alliance. 5. PMID 34880103 DOI: 10.26508/lsa.202101217 |
0.192 |
|
1997 |
Appelbaum M, Batten DA, Belsky J, Booth C, Bradley R, Brownell C, Caldwell B, Campbell S, Clarke-Stewart A, Cohn J, Cox M, Fendt K, Friedman S, Goldberg W, Greenberger E, et al. Familial factors associated with the characteristics of nonmaternal care for infants Journal of Marriage and Family. 59: 389-408. DOI: 10.2307/353478 |
0.188 |
|
2023 |
Dunker W, Zaver SA, Pineda JMB, Howard CJ, Bradley RK, Woodward JJ. The proto-oncogene SRC phosphorylates cGAS to inhibit an anti-tumor immune response. Jci Insight. PMID 37166992 DOI: 10.1172/jci.insight.167270 |
0.174 |
|
2023 |
Parrish PCR, Groso DJ, Thomas JD, Bradley RK, Berger AH. pgMAP: a pipeline to enable guide RNA read mapping from dual-targeting CRISPR screens. Arxiv. PMID 37396617 |
0.143 |
|
2012 |
Xie Q, Bradley R, Kang L, Koeman J, Ascierto ML, Worschech A, De Giorgi V, Wang E, Kefene L, Su Y, Essenburg C, Kaufman DW, DeKoning T, Enter MA, O'Rourke TJ, et al. Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma. Proceedings of the National Academy of Sciences of the United States of America. 109: 570-5. PMID 22203985 DOI: 10.1073/Pnas.1119059109 |
0.143 |
|
2012 |
Yang FH, Zhang B, Zhou DJ, Bie L, Tom MW, Drummond DC, Nicolaides T, Mueller S, Banerjee A, Park JW, Prados MD, James DC, Gupta N, Hashizume R, Strohbehn GW, ... ... Bradley R, et al. LAB-EXPERIMENTAL (PRE-CLINICAL) THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 14: vi25-vi37. DOI: 10.1093/Neuonc/Nos222 |
0.134 |
|
2018 |
Li X, Tao Y, Bradley R, Du Z, Tao Y, Kong L, Dong Y, Jones J, Yan Y, Harder CRK, Friedman LM, Bilal M, Hoffmann B, Zhang SC. Fast Generation of Functional Subtype Astrocytes from Human Pluripotent Stem Cells. Stem Cell Reports. PMID 30269954 DOI: 10.1016/J.Stemcr.2018.08.019 |
0.13 |
|
2021 |
Li S, Simoni Y, Zhuang S, Gabel A, Ma S, Chee J, Islas L, Cessna A, Creaney J, Bradley RK, Redwood A, Robinson BW, Newell EW. Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34285073 DOI: 10.1073/pnas.2025570118 |
0.119 |
|
2021 |
Li S, Simoni Y, Zhuang S, Gabel A, Ma S, Chee J, Islas L, Cessna A, Creaney J, Bradley RK, Redwood A, Robinson BW, Newell EW. Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34285073 DOI: 10.1073/pnas.2025570118 |
0.119 |
|
2024 |
Lo Y, Lester SC, Ellis IO, Lanjewar S, Laurini J, Patel A, Bhattarai A, Ustun B, Harmon B, Kleer CG, Ross D, Amin A, Wang Y, Bradley R, Turashvili G, et al. Identification of Glandular (Acinar)/Tubule Formation in Invasive Carcinoma of the Breast: A Study to Determine Concordance Using the World Health Organization Definition. Archives of Pathology & Laboratory Medicine. PMID 38244086 DOI: 10.5858/arpa.2023-0163-OA |
0.102 |
|
2017 |
Odigwe C, Bradley R, Arya RR. Pleural-based granular cell tumor. Proceedings (Baylor University. Medical Center). 30: 319-321. PMID 28670071 |
0.093 |
|
2011 |
Xie Q, Wondergem R, Shen Y, Cavey G, Ke J, Thompson R, Bradley R, Daugherty-Holtrop J, Daughtery-Holtrop J, Xu Y, Chen E, Omar H, Rosen N, Wenkert D, Xu HE, et al. Benzoquinone ansamycin 17AAG binds to mitochondrial voltage-dependent anion channel and inhibits cell invasion. Proceedings of the National Academy of Sciences of the United States of America. 108: 4105-10. PMID 21368131 DOI: 10.1073/Pnas.1015181108 |
0.088 |
|
2013 |
Kyselková M, Jirout J, Chroňáková A, Vrchotová N, Bradley R, Schmitt H, Elhottová D. Cow excrements enhance the occurrence of tetracycline resistance genes in soil regardless of their oxytetracycline content. Chemosphere. 93: 2413-8. PMID 24053942 DOI: 10.1016/j.chemosphere.2013.08.058 |
0.065 |
|
2016 |
Rousk K, Degboe J, Michelsen A, Bradley R, Bellenger JP. Molybdenum and phosphorus limitation of moss-associated nitrogen fixation in boreal ecosystems. The New Phytologist. PMID 27883187 DOI: 10.1111/Nph.14331 |
0.064 |
|
2013 |
Goldman JW, Raju RN, Gordon GA, El-Hariry I, Teofilivici F, Vukovic VM, Bradley R, Karol MD, Chen Y, Guo W, Inoue T, Rosen LS. A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies. Bmc Cancer. 13: 152. PMID 23530663 DOI: 10.1186/1471-2407-13-152 |
0.061 |
|
2018 |
Ayers S, Crawley R, Button S, Thornton A, Field AP, Flood C, Lee S, Eagle A, Bradley R, Moore D, Gyte G, Smith H. Evaluation of expressive writing for postpartum health: a randomised controlled trial. Journal of Behavioral Medicine. PMID 30291538 DOI: 10.1007/S10865-018-9970-3 |
0.06 |
|
1999 |
Ying J, Bradley RK, Jones LB, Reddy MS, Colbert DT, Smalley RE, Hardin SH. Guanine-rich telomeric sequences stimulate DNA polymerase activity in vitro. Biochemistry. 38: 16461-8. PMID 10600107 DOI: 10.1021/Bi9918543 |
0.058 |
|
2019 |
Hale K, Østbye T, Perera B, Bradley R, Maselko J. A Novel Adaptation of the HOME Inventory for Elders: The Importance of the Home Environment Across the Life Course. International Journal of Environmental Research and Public Health. 16. PMID 31398802 DOI: 10.3390/ijerph16162826 |
0.052 |
|
2020 |
Wang L, Liu F, Ning Y, Bradley R, Yang C, Yong KT, Zhao B, Wu W. Biocompatible Mesoporous Hollow Carbon Nanocapsules for High Performance Supercapacitors. Scientific Reports. 10: 4306. PMID 32152348 DOI: 10.1038/S41598-020-61138-4 |
0.052 |
|
2010 |
O'Grady JG, Asderakis A, Bradley R, Burnapp L, McPake DM, Perrin M, Russell S, Watson AR, Watson CJ, Wray J, Wilson LC. Multidisciplinary insights into optimizing adherence after solid organ transplantation. Transplantation. 89: 627-32. PMID 20124952 DOI: 10.1097/TP.0b013e3181ca87b0 |
0.049 |
|
2018 |
Crawley R, Ayers S, Button S, Thornton A, Field AP, Lee S, Eagle A, Bradley R, Moore D, Gyte G, Smith H. Feasibility and acceptability of expressive writing with postpartum women: a randomised controlled trial. Bmc Pregnancy and Childbirth. 18: 75. PMID 29580213 DOI: 10.1186/S12884-018-1703-7 |
0.045 |
|
1974 |
Bradley RK, Werezak GN. USE OF HYDROGEN CHLORIDE TO GENERATE ClO//2 Tappi. 57: 98-101. |
0.044 |
|
2019 |
Waghchoure S, Bradley R, Sorrell M, Arya R. Successful rigid bronchoscopic resection of recurrent pulmonary inflammatory myofibroblastic tumor after complete surgical resection. Proceedings (Baylor University. Medical Center). 32: 408-410. PMID 31384203 DOI: 10.1080/08998280.2019.1612688 |
0.042 |
|
2022 |
Darnajoux R, Bradley R, Bellenger JP. Temperature Dependency of Molybdenum and Vanadium Nitrogenase Activity in the Heterocystous Cyanobacteria . Environmental Science & Technology. 56: 2760-2769. PMID 35073047 DOI: 10.1021/acs.est.1c05279 |
0.037 |
|
1998 |
Liu J, Rinzler AG, Dai H, Hafner JH, Bradley RK, Boul PJ, Lu A, Iverson T, Shelimov K, Huffman CB, Rodriguez-Macias F, Shon YS, Lee TR, Colbert DT, Smalley RE. Fullerene pipes Science (New York, N.Y.). 280: 1253-6. PMID 9596576 DOI: 10.1126/science.280.5367.1253 |
0.032 |
|
2019 |
Liu F, Wang L, Bradley R, Zhao B, Wu W. Highly efficient solar seawater desalination with environmentally friendly hierarchical porous carbons derived from halogen-containing polymers. Rsc Advances. 9: 29414-29423. PMID 35528431 DOI: 10.1039/c9ra05637h |
0.031 |
|
2000 |
Zimmerman JL, Bradley RK, Huffman CB, Hauge RH, Margrave JL. Gas-phase purification of single-wall carbon nanotubes Chemistry of Materials. 12: 1361-1366. DOI: 10.1021/Cm990693M |
0.029 |
|
2012 |
Aulen M, Shipley B, Bradley R. Prediction of in situ root decomposition rates in an interspecific context from chemical and morphological traits. Annals of Botany. 109: 287-97. PMID 22003237 DOI: 10.1093/Aob/Mcr259 |
0.026 |
|
2010 |
Ford E, Ayers S, Bradley R. Exploration of a cognitive model to predict post-traumatic stress symptoms following childbirth. Journal of Anxiety Disorders. 24: 353-9. PMID 20176458 DOI: 10.1016/j.janxdis.2010.01.008 |
0.024 |
|
1999 |
Nikolaev P, Bronikowski MJ, Bradley RK, Rohmund F, Colbert DT, Smith KA, Smalley RE. Gas-phase catalytic growth of single-walled carbon nanotubes from carbon monoxide Chemical Physics Letters. 313: 91-97. DOI: 10.1016/S0009-2614(99)01029-5 |
0.021 |
|
2011 |
Rabe H, Jewison A, Alvarez RF, Crook D, Stilton D, Bradley R, Holden D. Milking compared with delayed cord clamping to increase placental transfusion in preterm neonates: a randomized controlled trial. Obstetrics and Gynecology. 117: 205-11. PMID 21252731 DOI: 10.1097/AOG.0b013e3181fe46ff |
0.019 |
|
2006 |
Nader PR, O'Brien M, Houts R, Bradley R, Belsky J, Crosnoe R, Friedman S, Mei Z, Susman EJ. Identifying risk for obesity in early childhood. Pediatrics. 118: e594-601. PMID 16950951 DOI: 10.1542/Peds.2005-2801 |
0.018 |
|
2012 |
Weinraub M, Bender RH, Friedman SL, Susman EJ, Knoke B, Bradley R, Houts R, Williams J. Patterns of developmental change in infants' nighttime sleep awakenings from 6 through 36 months of age. Developmental Psychology. 48: 1511-28. PMID 22448981 DOI: 10.1037/A0027680 |
0.018 |
|
2012 |
Sawyer A, Ayers S, Young D, Bradley R, Smith H. Posttraumatic growth after childbirth: a prospective study. Psychology & Health. 27: 362-77. PMID 21678177 DOI: 10.1080/08870446.2011.578745 |
0.014 |
|
1985 |
Bradley RK, Murch SH. Four cases of spinal cord compression: the need for early diagnosis. Journal of the Royal Naval Medical Service. 71: 92-5. PMID 4032342 |
0.014 |
|
2001 |
Bradley RK. What is the key to globalisation? [social aspects of automation] International Symposium On Technology and Society, Proceedings. 2001: 117-124. DOI: 10.1109/ISTAS.2001.937729 |
0.012 |
|
2024 |
Clifford BN, Eggum ND, Rogers A, Porter C, Gale M, Sheppard JA, Lucca K, Rainey V, Bradley R, Holmgren H, Jones B. Mothers' and fathers' depressive symptoms across four years postpartum: An examination of between- and bidirectional within-person relations. Journal of Affective Disorders. PMID 38290580 DOI: 10.1016/j.jad.2024.01.255 |
0.01 |
|
2017 |
Raffe SF, Savage C, Perry LA, Patel A, Keith T, Howell R, Bradley R, Bomont R, Fidler K, Gilleece Y. The management of HIV in pregnancy: A 10-year experience. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 210: 310-313. PMID 28110176 DOI: 10.1016/j.ejogrb.2016.12.021 |
0.01 |
|
2011 |
Bombelli P, McCormick A, Bradley R, Yunus K, Philips J, Anderson X, Cruz S, Thorne R, Gu N, Smith A, Bendall D, Howe C, Peter L, Fisher A. Harnessing solar energy by bio-photovoltaic (BPV) devices. Communications in Agricultural and Applied Biological Sciences. 76: 89-91. PMID 21404943 |
0.01 |
|
Hide low-probability matches. |